U.S. District Court rules in favor of Watson over Mucinex patent suit

Links shared publicly online about this topic.

163
total visits

U.S. District Court rules in favor of Watson over Mucinex patent suit

Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R), Mucinex(R) D, and Mucinex(R) DM Extended-Release products do not infringe U.S. Patent No. 6,372,252.

View full resource at news-medical.net

Tags: Pharma, Watson Pharmaceuticals

Most Recently Shared on July 8, 2011 at 5:09 am By:

News-Medical.Net

U.S. District Court rules in favor of Watson over Mucinex patent suit: Watson Pharmaceuticals, Inc. today confir... http://bit.ly/o4uqGR

9 months ago...

Retweet

Favorite

Also Shared By:

News-Medical.Net

US District Court rules in favor of Watson in generic Mucinex patent infringement suit

news-medical.net — “Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.” View full resource at news-medical.net